GlaxoSmithKline CEO reshuffles 40% of management team in bid to bring in new ideas
admin 9th January 2018 Uncategorised 0GlaxoSmithKline CEO Emma Walmsley has grabbed headlines with some of the top management changes she’s made since taking the helm in March, namely poaching Luke Miels from rival AstraZeneca to head up pharmaceuticals, and appointing Roche and Calico veteran Hal Barron as CSO. But behind the scenes, her scalpel has actually cut much deeper.
More: GlaxoSmithKline CEO reshuffles 40% of management team in bid to bring in new ideas
Source: fierce